Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2015

Open Access 01-12-2015 | Research article

Prevention of cell-surface attachment and reduction of penicillin-binding protein 2a (PBP2a) level in methicillin-resistant Staphylococcus aureus biofilms by Acalypha wilkesiana

Authors: Carolina Santiago, Kuan-Hon Lim, Hwei-San Loh, Kang Nee Ting

Published in: BMC Complementary Medicine and Therapies | Issue 1/2015

Login to get access

Abstract

Background

Formation of biofilm is known to enhance the virulence of methicillin-resistance Staphylococcus aureus (MRSA), which is associated with persistent infections in hospital settings. The biofilm layer essentially forms a protective barrier encapsulating the bacterial colony and thus reduces the effectiveness of chemotherapeutics. We have isolated 9EA-FC-B bioactive fraction from Acalypha wilkesiana Müll. Arg. that reverses ampicillin resistant in MRSA through inhibition of the antibiotic resistant protein, penicillin-binding protein 2a (PBP2a). In this study, we aimed to investigate the effects of 9EA-FC-B on MRSA biofilm forming capacity.

Methods

Inhibition of biofilm production and microtiter attachment assays were employed to study the anti-biofilm activity of 9EA-FC-B, while latex agglutination test was performed to investigate the effect on PBP2a in the biofilm matrix. We also attempted to characterise the chemical components of the fraction using high performance liquid chromatography (HPLC) and phytochemical analysis.

Results

Fraction 9EA-FC-B and ampicillin exhibited similar inhibitory effect on MRSA’s biofilm production at their respective minimum inhibitory concentrations (81.56% vs 84.49%, respectively). However, the test fraction was more effective in suppressing cell surface attachment (90.85%) compared to ampicillin (37.8%). Interestingly, ampicillin enhanced the level PBP2a and in the contrary 9EA-FC-B attenuated the production of the resistant protein in the bioflim matrix. HPLC and phytochemical analysis revealed that 9EA-FC-B fraction is a complex mixture containing tannins, saponins, sterol/steroids, and glycosides.

Conclusions

Bioactive fraction 9EA-FC-B inhibited the production of MRSA biofilm by preventing the initial cell-surface attachment and reducing the amount PBP2a in the matrix. PBP2a found in the biofilm matrix is believed to have a role in the development of virulence in MRSA.
Literature
1.
Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–22. doi:10.1126/science.284.5418.1318.CrossRefPubMed
2.
3.
Petrelli D, Repetto A, D’Ercole S, Rombini S, Ripa S, Prenna M, et al. Analysis of meticillin-susceptible and meticillin-resistant biofilm-forming Staphylococcus aureus from catheter infections isolated in a large Italian hospital. J Med Microbiol. 2008;57(Pt 3):364–72. doi:10.1099/jmm. 0.47621-0.CrossRefPubMed
4.
Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, Chandramohan L, et al. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS One. 2009;4:e5822. doi:10.1371/journal.pone.0005822.CrossRefPubMedPubMedCentral
5.
Del Pozo JL, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther. 2007;82:204–9. doi:10.1038/sj.clpt.6100247.CrossRefPubMed
6.
Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–93. doi:10.1128/CMR. 15.2.167-193.2002.CrossRefPubMedPubMedCentral
7.
Berger-Bächi B, Rohrer S. Factors influencing methicillin resistance in Staphylococci. Arch Microbiol. 2002;178:165–71. doi:10.1007/s00203-002-0436-0.CrossRefPubMed
8.
Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, et al. Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections. PLoS Pathog. 2012;8:e1002626. doi:10.1371/journal.ppat.1002626.CrossRefPubMedPubMedCentral
9.
Gibbons S. Anti-staphylococcal plant natural products. Nat Prod Rep. 2004;21:263–77. doi:10.1039/b212695h.CrossRefPubMed
10.
Saleem M, Nazir M, Ali MS, Hussain H, Lee YS, Riaz N, et al. Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep. 2010;27:238–54. doi:10.1039/b916096e.CrossRefPubMed
11.
Abreu AC, McBain AJ, Simões M. Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep. 2012;29:1007–21. doi:10.1039/c2np20035j.CrossRefPubMed
12.
Alande PI. Irobi: antimicrobial activities of crude leaf extracts of acalypha wilkesiana. J Ethnopharmacol. 1993;39:171–41. doi:10.1016/03788741(93)90033-2.CrossRef
13.
Akinde BE, Odeyemi OO. Extraction and microbiological evaluation of the oils from the leaves of Acalypha wilkesiana. Niger Med J. 1987;17:163–5.
14.
Lim SW, Loh HS, Ting KN, Bradshaw TD, Zeenathul NA. Acalypha wilkesiana extracts induce apoptosis by causing single strand and double strand DNA breaks. J Ethnopharmacol. 2011;2:616–23. doi:10.1016/j.jep.2011.10.005.CrossRef
15.
Santiago C, Pang EL, Lim KH, Loh HS, Ting KN. Reversal of Ampicillin Resistance in MRSA via Inhibition of Penicillin-Binding Protein 2a by Acalypha wilkesiana. BioMed Res Int 2014, ID 965348. doi:10.1155/2014/965348.
16.
Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis. 2006;6:156. doi:10.1186/1471-2334-6-156.CrossRefPubMedPubMedCentral
17.
Mataraci E, Dosler S. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 2012;56:6366–71. doi:10.1128/AAC. 01180-12.CrossRefPubMedPubMedCentral
18.
Chung PY, Chung LY, Navaratnam P. Transcriptional profiles of the response of methicillin-resistant Staphylococcus aureus to pentacyclic triterpenoids. PLoS One. 2013;8:e56687. doi:10.1371/journal.pone.0056687.CrossRefPubMedPubMedCentral
19.
Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, et al. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol. 2004;42:1875–84. doi:10.1128/JCM. 42.5.1875-1884.2004.CrossRefPubMedPubMedCentral
20.
Jones WP, Kinghorn AD. Extraction of Plant Metabolites. In: Sarker SD, Latif AI, Gray AI, editors. Natural Product Isolation. New Jersey: Humana Press; 2005. p. 323–51.
21.
Othman M, Loh HS, Wiart C, Khoo TJ, Lim KH, Ting KN. Optimal methods for evaluating antimicrobial activities from plant extracts. J Microbiol Methods. 2011;84:161–6. doi:10.1016/j.mimet.2010.11.008.CrossRefPubMed
22.
Durham-Colleran MW, Verhoeven AB, van Hoek ML. Francisella novicida forms in vitro biofilms mediated by an orphan response regulator. Microb Ecol. 2010;59:457–65. doi:10.1007/s00248-009-9586-9.CrossRefPubMed
23.
Overhage J, Campisano A, Bains M, Torfs ECW, Rehm BHA, Hancock REW. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun. 2008;76:4176–82. doi:10.1128/IAI. 00318-08.CrossRefPubMedPubMedCentral
24.
Zhao W, Hu Z, Okubo S, Hara Y. Mechanism of synergy between epigallocatechin gallate and β -Lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001;45:1737–42. doi:10.1128/AAC. 45.6.1737-1742.2001.CrossRefPubMedPubMedCentral
25.
Olson KM, Starks CM, Williams RB, O’Neil-Johnson M, Huang Z, Ellis M, et al. Novel pentadecenyl tetrazole enhances susceptibility of methicillin-resistant Staphylococcus aureus biofilms to gentamicin. Antimicrob Agents Chemother. 2011;55:3691–5. doi:10.1128/AAC. 00302-11.CrossRefPubMedPubMedCentral
26.
Al-Bakri AG, Othman G, Afifi FU. Determination of the antibiofilm, antiadhesive, and anti-MRSA activities of seven Salvia species. Pharmacogn Mag. 2010;6:264–70. doi:10.4103/0973-1296.71786.CrossRefPubMedPubMedCentral
27.
Quave CL, Plano LRW, Pantuso T, Bennett BC. Effects of extracts from Italian medicinal plants on planktonic growth, biofilm formation and adherence of methicillin-resistant Staphylococcus aureus. J Ethnopharmacol. 2008;118:418–28. doi:10.1016/j.jep.2008.05.005.CrossRefPubMedPubMedCentral
28.
Lim SW, Loh HW, Ting KN, Bradshaw TD, Zeenathul NA. Acalypha wilkesiana ethyl acetate extract enhances the in vitro cytotoxic effects of α-tocopherol in human brain and lung cancer cells. Int J Biosci Biochem Bioinforma. 2013;3:335–40. doi:10.7763/IJBBB.2013.V3.226.
29.
Din WM, Jin KT, Ramli R, Khaithir TMN, Wiart C. Antibacterial effects of ellagitannins from Acalypha wilkesiana var. macafeana hort.: surface morphology analysis with environmental scanning electron microscopy and synergy with antibiotics. Phytother Res. 2013;27:1313–20. doi:10.1002/ptr.4876.CrossRefPubMed
30.
Carpentier B, Cerf O. Biofilms and their consequences, with particular reference to hygiene in the food industry. J Appl Bacteriol. 1993;75:499–511. doi:10.1111/j.1365-2672.1993.tb01587.x.CrossRefPubMed
31.
Zhao WH, Hu ZQ, Hara Y, Shimamura T. Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46:2266–8. doi:10.1128/AAC. 46.7.2266-2268.2002.CrossRefPubMedPubMedCentral
32.
Yoda Y, Hu ZQ, Zhao WH, Shimamura T. Different susceptibilities of Staphylococcus and gram-negative rods to epigallocatechin gallate. J Infect Chemother. 2004;10:55–8. doi:10.1007/s10156-003-0284-0.CrossRefPubMed
33.
O’Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol. 2000;54:49–79. doi:10.1146/annurev.micro.54.1.49.CrossRefPubMed
Metadata
Title
Prevention of cell-surface attachment and reduction of penicillin-binding protein 2a (PBP2a) level in methicillin-resistant Staphylococcus aureus biofilms by Acalypha wilkesiana
Authors
Carolina Santiago
Kuan-Hon Lim
Hwei-San Loh
Kang Nee Ting
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2015
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-015-0615-6

Other articles of this Issue 1/2015

BMC Complementary Medicine and Therapies 1/2015 Go to the issue

Research article

Antibacterial and antibiotic resistance modifying activity of the extracts from allanblackia gabonensis, combretum molle and gladiolus quartinianus against Gram-negative bacteria including multi-drug resistant phenotypes

Research article

Induction of apoptosis and oxidative stress in estrogen receptor-negative breast cancer, MDA-MB231 cells, by ethanolic mango seed extract

Research article

Inhibitory effect of Clitoria ternatea flower petal extract on fructose-induced protein glycation and oxidation-dependent damages to albumin in vitro

Research article

Evaluation of anthelmintic potential of the Ethiopian medicinal plant Embelia schimperi Vatke in vivo and in vitro against some intestinal parasites

Research article

XiangshaLiujunzi decoction alleviates the symptoms of functional dyspepsia by regulating brain–gut axis and production of neuropeptides

Research article

Prevalence and modes of complementary and alternative medicine use among peasant farmers with musculoskeletal pain in a rural community in South-Western Nigeria